OpenAI grows stable of law firms for high-stakes lawsuits, deals

OpenAI’s legal position improved after defeating Elon Musk’s lawsuit over its nonprofit mission, removing a potential hurdle ahead of a possible IPO as soon as September. Reuters says OpenAI is now working with more than a dozen major U.S. law firms across fundraising, IPO preparation and multiple lawsuits, underscoring the scale of its legal and strategic activity. The article also notes Matthew Schwartz of Sullivan & Cromwell disclosed $7.36 million in partner compensation before his federal appeals court nomination.

Analysis

The strategic signal here is less about legal billings and more about capital-markets readiness: once a private AI leader starts building an IPO-grade litigation perimeter, it usually means management is trying to compress perceived execution risk ahead of a public listing. That tends to benefit the ecosystem’s “picks-and-shovels” public names first—especially the hyperscalers and chip suppliers that would be leaned on as proof points for durable demand—while putting downward pressure on any adjacent vendor lacking defensible IP or contractual protections.

The bigger second-order effect is that an OpenAI float, if it happens into late Q3, could reset AI valuation comparables across the software stack. Public investors will likely reprice the market away from pure model novelty and toward governance, indemnification, and distribution durability; that is a net positive for Microsoft and Nvidia if the IPO narrative validates enterprise adoption, but a relative headwind for Apple if the market begins to frame device-side AI as strategically late versus cloud-native AI. The per-ticker skew in the data fits that: MSFT/NVDA get a modest positive read-through, AAPL slightly negative.

On risk, the legal win removes one near-term overhang, but it does not de-risk the heavier tail risks: copyright discovery, antitrust escalation, and trade-secret claims can all linger for 6-18 months and create repeated event risk around financing, partnerships, and eventually the IPO S-1. The consensus may be underestimating how an IPO would surface model-economics scrutiny: revenue growth could be celebrated, but margin structure, compute intensity, and dependency on a few strategic counterparties may compress the multiple more than bulls expect. That makes the setup better for relative-value than outright beta.

Contrarian takeaway: the market is likely to treat this as a clean regulatory/IPO positive, but the more important implication is that OpenAI is moving from venture-style optionality to public-market accountability. That transition usually narrows the valuation gap between “AI infrastructure” and “AI application” winners, because the former have cleaner unit economics and lower litigation risk. If the IPO window opens, expect multiple dispersion—not just an AI uplift.

Key Decisions for Investors

• Long MSFT / short AAPL into the next 1-3 months: MSFT should benefit most from any OpenAI IPO validation and ecosystem re-rating, while AAPL faces a relative narrative penalty if cloud AI remains the dominant profit pool. Target 5-8% relative outperformance; cut if Apple announces a meaningful AI distribution partnership that closes the gap.
• Add to NVDA on pullbacks over the next 2-6 weeks: an OpenAI IPO would likely reinforce the scarcity value of frontier compute and keep capex expectations elevated. Use call spreads to cap downside; favorable if AI capital formation remains intense through the summer.
• Buy a small basket long of AI infrastructure names versus a short basket of AI application names lacking proprietary data moats, with a 3-6 month horizon. The trade should benefit if public-market scrutiny shifts toward unit economics and away from top-line growth.
• Avoid chasing upside in “IPO beneficiaries” until filing risk is clearer: if OpenAI files by September, expect a temporary overhang in comparable private software names as investors demand governance discounts. Use any pre-IPO strength to reduce exposure in high-duration AI software.
• Optionality trade: buy MSFT October upside calls or call spreads as a low-event-risk expression on ecosystem validation. This offers asymmetric participation if the IPO or related partnership headlines land, with limited premium at risk.